GlaxoSmithKline CEO shoots for 'at least' six FDA drug approvals in 2020

(1:44)

GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC

(9:47)

Drugmaker GlaxoSmithKline 'guilty of fraud'

(2:5)

Glaxo Gets Ready to Split in Two

(6:39)

GlaxoSmithKline announces $300 million equity investment in 23andMe

(3:28)

GlaxoSmithKline to Pay $3 Billion Fine

(1:34)

GlaxoSmithKline publie de modestes résultats trimestriels - economy

(55)

Here’s How GlaxoSmithKline Is Able to Turn a Profit

(2:33)

GlaxoSmithKline Receives $54.4 Million Fine In UK For Pay-For-Delay Deal

(2:37)

GlaxoSmithKline bribery probe widens - economy

(36)

GlaxoSmithKline on Vaccines

(4:54)

GlaxoSmithKline (GSK) - Company Presentation

(11:1econd)

10 \

(10:21)

Distinguished Speaker Series: A Conversation with GSK CEO Emma Walmsley

(50:27)

Emma Walmsley, GSK's CEO, in a conversation with Sarah Neville

(20:30)

GlaxoSmithKline STARLIMS Implementation Case Study

(46:47)

The David Rubenstein Show: GSK CEO Emma Walmsley

(24:6)

BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline

(55:47)

Emma Walmsley summarises our agreement with Pfizer to form a Consumer Healthcare Joint Venture.

(3:51)

Letting Science Drive Technology at GlaxoSmithKline

(32:15)

GlaxoSmithKline to stop paying doctors by 2016

(1:13)

CEO of GlaxoSmithKline speaks about HIV and the pharmaceutical industry

(2:41)

GlaxoSmithKline Takes the Top Spot on Fortune’s Change the World List | Fortune

(2:47)

GlaxoSmithKline Planning Ebola Vaccine: Altenpohl

(4:27)

Prix Galien USA 2019 / Best Pharmaceutical Product: GlaxoSmithKline SHINGRIX

(1:25)

GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing

(10:20)

Our global commitment to oncology

(2:36)